SignPath Pharma, Inc.
PrivateLast Round
VC Round
Jul 25, 2025
Total Funding Raised
$847,500
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SignPath Pharma, Inc. is a clinical-stage biotechnology company that develops proprietary liposomal formulations of curcumin and other therapeutics to treat cancer and mitigate cardiac side effects.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SignPath Pharma, Inc. Comparables
Compare SignPath Pharma, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bexion Pharmaceuticals | 78% | |
| ForDoz Pharma Corp. | 77% | |
| Moleculin Biotech, Inc. | 73% | |
SignPath Pharma, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 25, 2025 | ||||
| Private Placement | Jul 26, 2011 | ||||
| Debt | Apr 1, 2008 |
Key People
Founding team and executive leadership
SignPath Pharma, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Wickfield Capital | VC Round |
| Loop Capital Markets LLC | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
Monthly visitors increased 38% MoM, reaching 2.2K.
- Apr 17, 2026
Monthly visitors grew 177% MoM, reaching 1.6K.
SignPath Pharma, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SignPath Pharma, Inc.'s valuation, stock price, and market status.